Creating and distributing additional copies is prohibited without the permission of the publisher. Contact subscriptions@latinfinance.com.

Ache Itches to Go Public

Dec 1, 2009

Amid growing investor appetite for an IPO from the still untapped Brazil pharmaceutical industry, Ache, one of the country’s leading drug companies, is heard in advanced talks to go public. Brazil’s largest investors, including portfolio managers at Itau-Unibanco Asset Management (IUAM) and Bradesco Asset Management (BRAM), say a substantial, well-run company from that sector would draw significant...

To continue reading please take a free trial, subscribe or login below.


Already have an account?

Subscribe

Subscribe now for unlimited access to all current and archive news, data and market analysis. 

Subscribe

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial

LatinFinance Events

Poll

How busy will LatAm global-local currency debt issuance be this year?

Vote    



  1. Commodities dip raises LatAm growth fears
  2. LatAm banks return to syndicated loan market
  3. Institutional wealth – pension funds: The next generation
  4. Cemex enters “new phase” – CFO
  5. Debt investor scorecard: Beating the benchmark
Follow us


Popular Searches


It’s going to be a tough road for [Maduro]. Given the blow to Chavismo with the death of Chavez, there is a real likelihood of some form of real change in Venezuela.

Kathryn Rooney Vera, Bulltick Capital Markets


Change font size: Switch to default font size Switch to medium font size Switch to large font size

All material is subject to strictly enforced copyright terms & conditions and cannot be repurposed or reproduced. © 2013 Latin American Financial Publications Inc.

Printing isn't available for this page.